Interviews

Bhuvana Sagar, MD, Discusses Maintaining Cost Efficiency While Using Biosimilars

November 1, 2020

Video

Bhuvana Sagar, MD, the national medical executive at Cigna Health Care, discusses the importance of maintaining cost efficiency when juggling multiple biosimilars for 1 originator in the practice setting.

Part 2: Chad Pettit on “Head-to-Head” Biologics Competition

October 29, 2020

Video

Chad Pettit, executive director of marketing and team leader for global biosimilar launches at Amgen, discusses the potential for a level playing field for biosimilars and reference products.

Part 1: Chad Pettit on Amgen’s Assessment of the US Biosimilar Marketplace

October 27, 2020

Video

Chad Pettit, MBA, executive director of marketing and team leader for global biosimilar launches at Amgen, discussed Amgen’s recent report on the state of the US biosimilars marketplace.

Sandoz’ Edward Li on Using Filgrastim to Ease the Risk of Febrile Neutropenia

October 20, 2020

Video

Edward Li, PharmD, director of Health Economics and Outcomes Research for Sandoz, discussed how biosimilar filgrastim (Zarxio) used as primary prophylaxis saves money and helps reduce the risk of febrile neutropenia in patients with cancer.

Thomas Wakim On Neuclone’s Early Dive Into Developing PD-1 Inhibitor Biosimilars

October 15, 2020

Video

Thomas Wakim, strategic analyst for Neuclone, discussed the company’s decision to break into the world of PD-1 inhibitors, its partnership with the Serum Institute in India, and Neuclone’s biosimilar pipeline.

Part 2: Ryan Cox on Whether Midsize Employers Have a Voice in Biosimilar Discussions

October 8, 2020

Video

Ryan Cox, vice president of the Access Experience Team at PRECISIONvalue, discusses whether midsize employers can participate in payer discussions on formulary placement.

Part 1: Ryan Cox on What Employers Need to Do to Boost Biosimilar Uptake

October 7, 2020

Video

Ryan Cox, vice president of the Access Experience Team at PRECISIONvalue, discusses what employers can do to encourage biosimilar uptake and what cultural changes are needed to make it happen.

Part 3: Sean McGowan on the Current Biosimilar Markets to Keep an Eye On

October 3, 2020

Video

Sean McGowan, senior director of biosimilars at AmerisouceBergen, discussed the current biosimilar pipeline and the potential impact on the market those products may have.

Part 2: Sean McGowan on Ensuring a Future Competitive Biosimilar Market

October 1, 2020

Video

Sean McGowan, senior director of Biosimilars at AmerisourceBergen, discusses the physician and practice issues with having multiple biosimilars for the same molecule on the market and what is needed to ensure more biosimilar competition in the future.

Part 1: Sean McGowan on the Challenges of Bringing a Biosimilar to Market

September 29, 2020

Video

Sean McGowan, senior director of Biosimilars at AmerisourceBergen, discussed the challenges of bringing a new biosimilar to market both generally and during the time of the coronavirus disease 2019 (COVID-19) pandemic.

x